Fusion Antibodies remains in growth mode as revenues lift by 7 per cent

Retrieved on: 2021-08-11 00:11:15

Tags for this article:

Medical specialties

Immunology

Click the tags to see associated articles and topics

Fusion Antibodies remains in growth mode as revenues lift by 7 per cent. View article details on hiswai:

Excerpt

The global monoclonal antibody therapeutics market was valued at $135 billion in 2018 and is forecast to surpass $212 billion by next year. In 2017 ...

Article found on: www.irishnews.com

View Original Article